These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14610296)

  • 21. Deterministic construct of amplifying actions of ghrelin on pulsatile growth hormone secretion.
    Farhy LS; Veldhuis JD
    Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1649-63. PubMed ID: 15718392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone-releasing peptides.
    Ghigo E; Arvat E; Muccioli G; Camanni F
    Eur J Endocrinol; 1997 May; 136(5):445-60. PubMed ID: 9186261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Model-projected mechanistic bases for sex differences in growth hormone regulation in humans.
    Farhy LS; Bowers CY; Veldhuis JD
    Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1577-93. PubMed ID: 17185408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
    Bowers CY; Granda-Ayala R
    Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of somatostatin-receptor subtype-2/-5 suppresses the mass, frequency, and irregularity of growth hormone (GH)-releasing peptide-2-stimulated GH secretion in men.
    Iranmanesh A; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4581-7. PubMed ID: 15356066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5484-9. PubMed ID: 14602794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone-releasing hormone and growth hormone-releasing peptide as therapeutic agents to enhance growth hormone secretion in disease and aging.
    Thorner MO; Chapman IM; Gaylinn BD; Pezzoli SS; Hartman ML
    Recent Prog Horm Res; 1997; 52():215-44; discussion 244-6. PubMed ID: 9238854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The release of growth hormone (GH): relation to the thyrotropic- and corticotropic axis in the chicken.
    Kühn ER; Geelissen SM; Van der Geyten S; Darras VM
    Domest Anim Endocrinol; 2005 Jul; 29(1):43-51. PubMed ID: 15927766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy.
    Veldhuis JD; Keenan DM; Mielke K; Miles JM; Bowers CY
    Eur J Endocrinol; 2005 Oct; 153(4):577-86. PubMed ID: 16189179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep.
    Veldhuis JD; Iranmanesh A
    Sleep; 1996 Dec; 19(10 Suppl):S221-4. PubMed ID: 9085516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.
    Hudson SB; Schroeder DR; Bailey JN; Mielke KL; Erickson D; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2010 Jan; 95(1):353-60. PubMed ID: 19858315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.
    Catalina PF; Mallo F; Andrade MA; García-Mayor RV; Diéguez C
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3663-7. PubMed ID: 9768681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term testosterone supplementation relieves growth hormone autonegative feedback in men.
    Veldhuis JD; Evans WS; Iranmanesh A; Weltman AL; Bowers CY
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1285-90. PubMed ID: 15001624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of growth hormone-releasing peptides in healthy dogs and in dogs with pituitary-dependent hyperadrenocorticism.
    Bhatti SF; De Vliegher SP; Van Ham L; Kooistra HS
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):97-103. PubMed ID: 12431802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of GHRH and GHRP-2 treatment in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor, GH-secretagogue-receptor and somatostatin receptor mRNAs in ovine pituitary cells.
    Yan M; Hernandez M; Xu R; Chen C
    Eur J Endocrinol; 2004 Feb; 150(2):235-42. PubMed ID: 14763922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
    Iranmanesh A; South S; Liem AY; Clemmons D; Thorner MO; Weltman A; Veldhuis JD
    Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
    Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ghrelin-induced GH secretion in normal subjects is partially resistant to homologous desensitization by GH-releasing peptide-6.
    Micic D; Macut D; Sumarac-Dumanovic M; Kendereski A; Popovic V; Deghenghi R; Dieguez C; Casanueva FF
    Eur J Endocrinol; 2002 Dec; 147(6):761-6. PubMed ID: 12457451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral estrogen receptor-alpha selectively modulates the waveform of GH secretory bursts in healthy women.
    Veldhuis JD; Keenan DM; Bowers CY
    Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1514-21. PubMed ID: 17686882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.